Stock listing

NASDAQ:FUSN Fusion Pharmaceuticals Inc Stock

Follow Fusion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FUSN

$21.55 USD

Close on Jun 3, 2024 · No longer trades

Jun 26, 2020 to last close +26.8% · weekly closes, Jun 26, 2020 – Jun 3, 2024
Lowest – highest close
$1.98 – $21.55 USDSince Jun 26, 2020 · lowest Nov 7, 2022 · highest Jun 3, 2024

Delisted NASDAQ:FUSN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FUSN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Fusion Pharmaceuticals Inc on 6ix

Decks
7 decks · latest Mar 19, 2024

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2024)Merger or acquisition24 slidesMar 19, 2024
Investor Presentation (January 2024)Investor deck26 slidesJan 4, 2024
Technical Presentation (June 2023)Technical23 slidesJun 27, 2023
Merger or Acquisition (February 2023)Merger or acquisition27 slidesFeb 13, 2023
Investor Presentation (June 2022)Investor deck33 slidesJun 9, 2022
Corporate Update (March 2021)Corporate update12 slidesMar 2, 2021
Merger or Acquisition (November 2020)Merger or acquisition26 slidesNov 2, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Heather Preston
Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past)
Director · Jun 25, 2020 – Jun 14, 2023 · Past
Chau Quang Khuong
Other companies: Damora Therapeutics, Inc. (Director · Oct 28, 2020 – Jun 14, 2023 · Past); Whitehawk Therapeutics, Inc. (Director · Jun 18, 2019 – Jun 18, 2019 · Past); Synlogic Inc (Director · Jun 5, 2019 – Apr 20, 2021 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 22, 2023 · Past); Inspire Medical Systems, Inc. (Director · Apr 10, 2019 – Oct 9, 2020 · Past)
Director · Jun 25, 2020 – Jun 14, 2023 · Past
Jeremy Bender
Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
Barbara Duncan
Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Jun 16, 2024); Halozyme Therapeutics, Inc. (Director · Since at least Apr 25, 2024); Ovid Therapeutics Inc. (Director · Since at least Feb 22, 2024)
Director · Jun 4, 2024 – Jun 4, 2024 · Past
David Meek
Other companies: Cullinan Therapeutics, Inc. (Director · Since at least May 15, 2024); uniQure N.V. (Chairman of the Board · Since at least Feb 25, 2021); Entasis Therapeutics Holdings Inc (Director · Jun 10, 2020 – Jul 7, 2022 · Past)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
Donald A Bergstrom
Other companies: Relay Therapeutics, Inc. (President, R&D · Since at least Jul 15, 2020); Mersana Therapeutics Inc (Chief Medical Officer · Jun 27, 2017 – Feb 2, 2018 · Past)
Director · Apr 1, 2021 – Jun 4, 2024 · Past
John J Crowley
Other companies: Centessa Pharmaceuticals PLC (Chief Financial Officer · Since at least Jun 10, 2024); Charles River Laboratories International, Inc. (SVP, Chief Accounting Officer · May 24, 2016 – Oct 1, 2016 · Past)
Chief Financial Officer · Jun 25, 2020 – Jun 4, 2024 · Past
Teresa Bitetti
Other companies: Takeda Pharmaceutical Co. Ltd. (President, Global Oncology Business Unit · Since at least Jan 5, 2026); Aura Biosciences, Inc. (Director · Since at least Mar 31, 2025)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
Christopher P Leamon
Other companies: Endocyte Inc (Vice President of Research · Dec 21, 2011 – Dec 21, 2018 · Past)
Chief Scientific Officer · Nov 1, 2021 – Jun 4, 2024 · Past
Steven Gannon
Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least May 21, 2015)
Director · Jun 25, 2020 – Jun 4, 2024 · Past
All 14 people
PersonSeat
Dmitri BobilevChief Medical Officer · Nov 7, 2022 – Jun 4, 2024 · Past
Eric BurakChief Technology Officer · Jun 25, 2020 – Jun 4, 2024 · Past
John ValliantChief Executive Officer, Director · Jun 25, 2020 – Jun 4, 2024 · Past
Mohit RawatPresident & CBO · Sep 27, 2021 – Jun 4, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Fusion Pharmaceuticals Inc.